Mainolfi Nello 4
4 · Kymera Therapeutics, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Mainolfi Nello
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-05$32.07/sh+3,118$99,994→ 666,195 total - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-05−3,118→ 446,882 totalExercise: $32.07Exp: 2033-03-01→ Common Stock (3,118 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 1, 2023, subject to the reporting person's continued employment through each vesting date.